vs

Side-by-side financial comparison of BWX Technologies, Inc. (BWXT) and CLARIVATE PLC (CLVT). Click either name above to swap in a different company.

BWX Technologies, Inc. is the larger business by last-quarter revenue ($885.8M vs $585.5M, roughly 1.5× CLARIVATE PLC). BWX Technologies, Inc. runs the higher net margin — 10.5% vs -6.9%, a 17.4% gap on every dollar of revenue. On growth, BWX Technologies, Inc. posted the faster year-over-year revenue change (18.7% vs -1.4%). CLARIVATE PLC produced more free cash flow last quarter ($78.9M vs $56.8M). Over the past eight quarters, BWX Technologies, Inc.'s revenue compounded faster (21.1% CAGR vs -5.1%).

BWX Technologies, Inc. is a company headquartered in Lynchburg, Virginia that supplies nuclear components and fuel internationally.

Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. Clarivate calculates the impact factor of scientific journals, using data from its Web of Science product family, that also includes services...

BWXT vs CLVT — Head-to-Head

Bigger by revenue
BWXT
BWXT
1.5× larger
BWXT
$885.8M
$585.5M
CLVT
Growing faster (revenue YoY)
BWXT
BWXT
+20.1% gap
BWXT
18.7%
-1.4%
CLVT
Higher net margin
BWXT
BWXT
17.4% more per $
BWXT
10.5%
-6.9%
CLVT
More free cash flow
CLVT
CLVT
$22.1M more FCF
CLVT
$78.9M
$56.8M
BWXT
Faster 2-yr revenue CAGR
BWXT
BWXT
Annualised
BWXT
21.1%
-5.1%
CLVT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BWXT
BWXT
CLVT
CLVT
Revenue
$885.8M
$585.5M
Net Profit
$93.0M
$-40.2M
Gross Margin
67.2%
Operating Margin
10.4%
5.2%
Net Margin
10.5%
-6.9%
Revenue YoY
18.7%
-1.4%
Net Profit YoY
30.9%
61.3%
EPS (diluted)
$1.02
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BWXT
BWXT
CLVT
CLVT
Q1 26
$585.5M
Q4 25
$885.8M
$617.0M
Q3 25
$866.3M
$623.1M
Q2 25
$764.0M
$621.4M
Q1 25
$682.3M
$593.7M
Q4 24
$746.3M
$663.0M
Q3 24
$672.0M
$622.2M
Q2 24
$681.5M
$650.3M
Net Profit
BWXT
BWXT
CLVT
CLVT
Q1 26
$-40.2M
Q4 25
$93.0M
$3.1M
Q3 25
$82.1M
$-28.3M
Q2 25
$78.4M
$-72.0M
Q1 25
$75.5M
$-103.9M
Q4 24
$71.0M
$-191.8M
Q3 24
$69.5M
$-65.6M
Q2 24
$73.0M
$-304.3M
Gross Margin
BWXT
BWXT
CLVT
CLVT
Q1 26
67.2%
Q4 25
66.8%
Q3 25
21.8%
65.0%
Q2 25
25.1%
67.2%
Q1 25
24.2%
65.1%
Q4 24
65.7%
Q3 24
24.4%
66.2%
Q2 24
24.7%
67.2%
Operating Margin
BWXT
BWXT
CLVT
CLVT
Q1 26
5.2%
Q4 25
10.4%
6.7%
Q3 25
13.1%
7.1%
Q2 25
13.4%
1.1%
Q1 25
14.2%
-3.5%
Q4 24
12.4%
-9.4%
Q3 24
14.4%
3.5%
Q2 24
14.5%
-36.9%
Net Margin
BWXT
BWXT
CLVT
CLVT
Q1 26
-6.9%
Q4 25
10.5%
0.5%
Q3 25
9.5%
-4.5%
Q2 25
10.3%
-11.6%
Q1 25
11.1%
-17.5%
Q4 24
9.5%
-28.9%
Q3 24
10.3%
-10.5%
Q2 24
10.7%
-46.8%
EPS (diluted)
BWXT
BWXT
CLVT
CLVT
Q1 26
$-0.06
Q4 25
$1.02
$0.00
Q3 25
$0.89
$-0.04
Q2 25
$0.85
$-0.11
Q1 25
$0.82
$-0.15
Q4 24
$0.77
$-0.27
Q3 24
$0.76
$-0.09
Q2 24
$0.79
$-0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BWXT
BWXT
CLVT
CLVT
Cash + ST InvestmentsLiquidity on hand
$499.8M
Total DebtLower is stronger
$4.3B
Stockholders' EquityBook value
$1.2B
$4.8B
Total Assets
$4.3B
$10.9B
Debt / EquityLower = less leverage
0.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BWXT
BWXT
CLVT
CLVT
Q1 26
Q4 25
$499.8M
$329.2M
Q3 25
$79.6M
$318.7M
Q2 25
$37.0M
$362.6M
Q1 25
$55.4M
$354.0M
Q4 24
$74.1M
$295.2M
Q3 24
$35.5M
$388.5M
Q2 24
$48.3M
$376.4M
Total Debt
BWXT
BWXT
CLVT
CLVT
Q1 26
$4.3B
Q4 25
$4.3B
Q3 25
$4.4B
Q2 25
$4.5B
Q1 25
$4.5B
Q4 24
$4.5B
Q3 24
$4.6B
Q2 24
$4.6B
Stockholders' Equity
BWXT
BWXT
CLVT
CLVT
Q1 26
$4.8B
Q4 25
$1.2B
$4.8B
Q3 25
$1.2B
$4.9B
Q2 25
$1.2B
$5.0B
Q1 25
$1.1B
$5.0B
Q4 24
$1.1B
$5.1B
Q3 24
$1.1B
$5.5B
Q2 24
$998.5M
$5.6B
Total Assets
BWXT
BWXT
CLVT
CLVT
Q1 26
$10.9B
Q4 25
$4.3B
$11.1B
Q3 25
$3.8B
$11.2B
Q2 25
$3.7B
$11.4B
Q1 25
$3.1B
$11.5B
Q4 24
$2.9B
$11.5B
Q3 24
$2.9B
$12.0B
Q2 24
$2.8B
$12.1B
Debt / Equity
BWXT
BWXT
CLVT
CLVT
Q1 26
0.89×
Q4 25
0.89×
Q3 25
0.90×
Q2 25
0.90×
Q1 25
0.90×
Q4 24
0.88×
Q3 24
0.84×
Q2 24
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BWXT
BWXT
CLVT
CLVT
Operating Cash FlowLast quarter
$127.0M
$134.7M
Free Cash FlowOCF − Capex
$56.8M
$78.9M
FCF MarginFCF / Revenue
6.4%
13.5%
Capex IntensityCapex / Revenue
7.9%
9.5%
Cash ConversionOCF / Net Profit
1.37×
TTM Free Cash FlowTrailing 4 quarters
$295.3M
$333.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BWXT
BWXT
CLVT
CLVT
Q1 26
$134.7M
Q4 25
$127.0M
$159.9M
Q3 25
$143.2M
$181.1M
Q2 25
$159.0M
$116.3M
Q1 25
$50.6M
$171.2M
Q4 24
$276.9M
$141.3M
Q3 24
$32.6M
$202.9M
Q2 24
$65.9M
$126.2M
Free Cash Flow
BWXT
BWXT
CLVT
CLVT
Q1 26
$78.9M
Q4 25
$56.8M
$89.2M
Q3 25
$94.9M
$115.5M
Q2 25
$126.3M
$50.3M
Q1 25
$17.3M
$110.3M
Q4 24
$224.4M
$59.1M
Q3 24
$-7.7M
$126.3M
Q2 24
$35.5M
$60.3M
FCF Margin
BWXT
BWXT
CLVT
CLVT
Q1 26
13.5%
Q4 25
6.4%
14.5%
Q3 25
11.0%
18.5%
Q2 25
16.5%
8.1%
Q1 25
2.5%
18.6%
Q4 24
30.1%
8.9%
Q3 24
-1.1%
20.3%
Q2 24
5.2%
9.3%
Capex Intensity
BWXT
BWXT
CLVT
CLVT
Q1 26
9.5%
Q4 25
7.9%
11.5%
Q3 25
5.6%
10.5%
Q2 25
4.3%
10.6%
Q1 25
4.9%
10.3%
Q4 24
7.0%
12.4%
Q3 24
6.0%
12.3%
Q2 24
4.5%
10.1%
Cash Conversion
BWXT
BWXT
CLVT
CLVT
Q1 26
Q4 25
1.37×
51.58×
Q3 25
1.74×
Q2 25
2.03×
Q1 25
0.67×
Q4 24
3.90×
Q3 24
0.47×
Q2 24
0.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BWXT
BWXT

Nuclear Component Program$436.4M49%
Nuclear Manufacturing$134.8M15%
Cost Plus Fee$116.1M13%
Uranium And Nuclear Services$103.8M12%
Commercial Operations$49.0M6%
Commercial Operations Segment$33.7M4%
Transferred At Point In Time$1.3M0%

CLVT
CLVT

Subscription$397.5M68%
Re-occurring$108.6M19%
Transactional$79.4M14%

Related Comparisons